Home › Products › Oncology › Epizee 50mg Injection
Epizee 50mg Injection
Salt Composition: EPIRUBICIN
- Manufacturer: ZEE LABORATORIES LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 50MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store Epizee 50mg injection in the refrigerator (2°C to 8°C) Do not freeze keep the injection away from the reach of children and pets. If you have missed any dosing appointments, inform your doctor and schedule immediately.
₹750.00₹1200.00
Inclusive of all taxes
Product Introduction
Epizee 50mg injection contains epirubicin hydrochloride, an antineoplastic agent belonging to the anthracycline class. It is used as adjuvant therapy in combination with other medications for patients with breast cancer who have undergone surgical tumour removal. This medicine is also indicated for patients with cancers of the breast, ovaries, stomach, bowel, and lung. Additionally, it is used to treat malignant haematological cancers including malignant lymphomas, leukaemias, and multiple myeloma.
Do not use this injection if you are allergic to epirubicin hydrochloride or any other ingredients, are pregnant or breastfeeding, or have severe liver and bladder impairment. Before starting treatment, inform your physician if you have kidney or liver problems, recent vaccination, or any acute toxicities such as acute oral inflammation, low white blood cell count, low platelet count, or active infection. This medicine may increase the risk of thromboembolism. This medicine may cause infertility in both men and women; inform your physician if you are planning pregnancy. If sexually active, effective contraception is advised to prevent pregnancy. Your physician will conduct regular laboratory tests to monitor the effects of this medicine.
Common side effects of Epizee 50mg injection include decreased white blood cell count, decreased platelets, irregular menstruation, weakness, nausea or vomiting, diarrhoea, ocular infection, skin rashes, or pruritus.
Uses
Breast cancer Stomach and bowel cancer Ovarian cancer Lung cancer
How it works
Epizee 50mg injection inhibits DNA, RNA, and protein synthesis by exerting cytotoxic activity. It works by slowing or stopping the growth of the cancer cells. This medicine helps to selectively kill cancer cells rather than normal, healthy cells.
How to Use
It should only be administered by a trained doctor or nurse experienced in giving chemotherapy. The medicine will be given as an infusion into a vein. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Hair loss Flushing Rash, itching Diarrhea Nausea and vomiting Anemia Decreased WBC and platelets Eye infection Irregular menstruation Serious Congestive heart failure Increased blood urea levels Severe hypersensitivity reaction Lung problems
Expert Tips
Inform your physician if you are receiving radiation therapy with this medicine. This medicine may cause birth defects if either partner uses it during conception or pregnancy. Male patients with female partners of reproductive potential should use effective birth control during the treatment and for 3 months after the last dose. Do not breastfeed during the treatment and for 7 days after the last dose. The medicine may turn your urine red for 1 or 2 days after your treatment.
References
- Epirubicin hydrochloride 2 mg/ml solution for injection - Summary of Product Characteristics (SmPC) - (emc). Medicines.org.uk. [revised on 2016] [cited 2023 Mar 31]. Available from: https://www.medicines.org.uk/emc/product/6361/smpc
- HIGHLIGHTS OF PRESCRIBING INFORMATION - Epirubicin. [revised on 2019] [cited 2023 Mar 31]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050778s024s025lbl.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 867.
Safety Advice
Pregnancy: unsafe Epizee 50mg injection is unsafe to administer in pregnant women because it may cause severe birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 6.5 months after your last dose is necessary.
Lungs: Consult your doctor It is unknown whether Epizee 50mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Epizee 50mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.